Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Company Information
About this company
Key people
Thomas Meier
Chief Executive Officer, Chief Operating Officer, Member of the Corporate Executive Committee
Anne-Kathrin Stoller
Chief Executive Officer, Member of the Corporate Executive Committee
Alain Schaffter
Chief Financial Officer, Member of the Corporate Executive Committee
Guenther Loidl
Chief Technology Officer, Member of the Corporate Executive Committee
Torsten Wohr
Chief Commercial Officer, Member of the Corporate Executive Committee
Kuno Sommer
Non-Executive Chairman of the Board
Nicole Grogg Hoetzer
Non-Executive Vice Chairwoman of the Board
Simone Wyss Fedele
Director
Peter Grogg
Director
Alex Faessler
Non-Executive Director
Click to see more
Key facts
- Shares in issue75.00m
- EPICBANB
- ISINCH1176493729
- LocationSwitzerland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capCHF 5.33bn
- Employees2,292
- ExchangeSIX Swiss Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.